Charles Schwab’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-6,722
Closed -$96K – 3593
2025
Q1
$96K Hold
6,722
– – ﹤0.01% 3348
2024
Q4
$166K Hold
6,722
– – ﹤0.01% 3347
2024
Q3
$204K Buy
6,722
+2,438
+57% +$95.5K ﹤0.01% 3335
2024
Q2
$219K Buy
4,284
+1,485
+53% +$115K ﹤0.01% 3428
2024
Q1
$249K Buy
+2,799
New +$283K ﹤0.01% 3206

Other funds holding GUTS

Charles Schwab's GUTS Position: Q2 2025 in Review

Charles Schwab sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 6,722 shares — an estimated $96K sold.

Charles Schwab first reported a position in GUTS in Q1 2024 and held it in 5 quarters. The position peaked at $249K in Q1 2024. 63 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

  • Charles Schwab reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab sold 6,722 Fractyl Health shares in Q2 2025, an estimated $96K.
  • Charles Schwab first reported a position in Fractyl Health in Q1 2024 and held it in 5 quarters.
  • Charles Schwab's Fractyl Health position peaked at $249K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.